Latest DEF 14A proxy statements

Eli Lilly and Company announced a definitive agreement to acquire Ventyx Biosciences, a clinical-stage biopharmaceutical company, for approximately $1.2 billion in cash.

Brighthouse Financial, a leading annuity and life insurance provider, will be acquired by Aquarian Holdings VI L.P. for $70.00 per share in an all-cash transaction.

Artelo Biosciences, Inc. has supplemented its proxy statement to include a new proposal for stockholder approval: the ratification of MaloneBailey LLP as its independent auditor for the fiscal year ending December 31, 2026, at its adjourned virtual Annual Meeting on January 30, 2026.

Gouverneur Bancorp, Inc. announced its 2026 Annual Meeting of Stockholders to be held on February 9, 2026, for the election of three directors and ratification of its independent accounting firm.

North European Oil Royalty Trust has filed definitive additional proxy materials with the SEC.

North European Oil Royalty Trust announces its 2026 Annual Meeting of Unit Owners to elect trustees and vote on managing director compensation, with proxy materials now available.

Columbus Acquisition Corp. filed a supplement to its proxy statement, detailing U.S. federal income tax considerations for shareholders regarding redemption rights and a proposed business combination deadline extension.

Timberland Bancorp, Inc. has updated its independent registered public accounting firm to Aprio, LLP following the merger of its previous auditor, Delap LLP, with Aprio, effective January 1, 2026.

Raymond James Financial, Inc. announces its 2026 Annual Meeting of Shareholders, detailing key proposals including director elections and executive compensation.

Raymond James Financial, Inc. has issued proxy materials and voting instructions for its 2026 Annual Shareholders Meeting, scheduled for February 19, 2026, for Employee Stock Ownership Plan participants.

Raymond James Financial, Inc. has filed definitive additional materials related to its proxy statement with the SEC.

Raymond James Financial, Inc. announced record fiscal 2025 results, including $14.1 billion in net revenues and $2.1 billion in net income, alongside proposals for director elections and amendments to its stock incentive and employee stock purchase plans.

Actelis Networks, Inc. will hold a special meeting on January 29, 2026, to seek shareholder approval for the issuance of common stock under a $30 million ELOC Purchase Agreement with White Lion Capital, LLC.

IES Holdings, Inc. has filed definitive additional materials related to its proxy statement under Section 14(a) of the Exchange Act.

IES Holdings, Inc. announces its 2026 virtual annual stockholders meeting, outlining director elections, auditor ratification, and executive compensation for fiscal years 2025 and 2026.

Keen Vision Acquisition Corporation filed definitive additional materials to correct a clerical error regarding its proposed quarterly extension fee for its trust account, setting it at $120,000 for each three-month extension.

iSpecimen Inc. filed an amendment to its proxy statement to clarify the quorum requirement for its 2025 Annual Meeting, reducing it to 34% of voting power.

Origin Materials, Inc. has filed definitive additional materials related to its proxy statement.

CNL Healthcare Properties files definitive proxy statement urging stockholders to approve its proposed $1.8 billion merger with Sonida Senior Living, Inc. for full liquidity.

Quipt Home Medical Corp. announced a special shareholder meeting on March 3, 2026, to vote on a proposed transaction involving 1567208 B.C. LTD and REM Aggregator, LLC.

Kala Bio, Inc. filed a supplement to its 2025 Proxy Statement, detailing new related party share issuances and an updated count of outstanding common stock.

Origin Materials, Inc. will hold a Special Meeting on February 17, 2026, to vote on a reverse stock split to maintain Nasdaq listing and the issuance of shares for up to $100 million in convertible notes.

Adial Pharmaceuticals, Inc. will hold a special meeting on February 26, 2026, to seek stockholder approval for the issuance of up to 13,823,512 shares of common stock related to Series F warrant exercises.

Twist Bioscience Corporation announces robust fiscal year 2025 financial performance, including record revenue and improved gross margin, ahead of its 2026 Annual Meeting of Stockholders.

Theriva Biologics, Inc. is calling a Special Meeting of Stockholders on February 11, 2026, to approve the issuance of up to 16,184,560 common shares from warrant exercises and an adjournment proposal.

California First Leasing Corporation seeks shareholder approval for a 1-for-50 reverse stock split to reduce shareholder count and deregister under the Investment Company Act of 1940.

Sonida Senior Living will acquire CNL Healthcare Properties in a cash and stock transaction valued at approximately $1.8 billion, creating the eighth largest U.S. senior living owner.

Templeton Emerging Markets Fund announces its 2026 Annual Meeting of Shareholders to vote on the election of four Trustees and the ratification of PricewaterhouseCoopers LLP as its independent auditor.

Powell Industries, Inc. announces its 2026 Annual Meeting of Stockholders to be held virtually on February 18, 2026, to elect directors and vote on executive compensation.

Denny's Corporation has filed a supplement to its definitive proxy statement regarding its merger with Sparkle Topco Corp. in response to shareholder lawsuits alleging misleading disclosures.